ARCHIVES

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 13 | March 28, 1986

Download PDF Visit The Full Archive

Related Articles

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System

December 15, 1989

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Funding opportunities listed.

November 19, 2004

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002